Showing 1 posts of 1 posts found.
GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO